全志科技(300458.SZ):擬出資4600萬元投資半導體產業投資基金
格隆匯 8 月 5日丨全志科技(300458.SZ)公佈,為充分藉助專業投資機構的專業資源及其投資管理優勢,促進公司長遠發展,公司擬作為有限合夥人以自有資金出資4600萬元人民幣投資鹽城經濟技術開發區臨芯志芯半導體產業投資基金(有限合夥)。
此次投資的投資方中全志科技董事長張建輝過往12個月內曾擔任東芯通信的董事長,董事丁然過往12個月內曾擔任東芯通信的董事。根據有關規定,東芯通信為公司關聯法人,此次對外投資構成關聯交易,但不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.